Biohazard Bag Market

Market Overview

The global biohazard bag market size was valued at USD 413 million in 2022 and is projected to reach USD 702 million by 2031, registering a CAGR of 6.2% during the forecast period (2023-2031).

A biohazard bag, also known as a biohazardous or biomedical waste bag, is designed to adequately contain and dispose of biohazardous refuse. These containers' red or orange markings indicate their purpose and potential peril. Biohazard containers are utilized in various contexts, including medical facilities, research laboratories, and industries that handle potentially infectious substances. They ensure the secure handling and disposal of infectious or potentially contaminated materials and are integral to biohazard waste management.

The rapidly expanding usage of biohazard bags in diagnostic and lab testing samples and growing use in nursing homes, hospitals, and long-term care institutions is likely to drive the market share. As a result, the market has much room to develop. Furthermore, with the fast-expanding e-commerce sales channel worldwide, the availability of biohazard bags has risen.

Highlights

• Less than 15 gallons lead the market based on capacity type.
• Medium pricing holds the major share based on price type.
• HDPE owns the highest share in the market based on material type
• By sales channel, third-party online channel holds a significant share.
• The commercial sector topped the market based on end-use.
• Based on application, other infectious segment is the highest contributor.
• North America is the dominating region.

Market Dynamics

Global Market Drivers

Increasing Healthcare Waste

The growing volume of healthcare waste is a major driving force in the worldwide market. As healthcare services develop and medical institutions handle more infectious and hazardous materials, the demand for efficient and secure waste disposal solutions, such as biohazard bags, grows. The ongoing epidemic of COVID-19 has underlined the essential need for efficient hospital waste management. Infectious waste generated by healthcare facilities, testing centers, and quarantine facilities includes worn personal protective equipment (PPE), infected medical supplies, and disposable products. Disposing of these items safely is critical to prevent the spread of illnesses among healthcare staff, patients, and the general public.

According to a World Health Organization (WHO) assessment, COVID-19 has increased healthcare waste creation, especially in hospitals and other medical institutions. Some nations reported a 200% to 300% increase in medical waste creation during the pandemic's height. Proper treatment and disposal of this material became a primary priority to reduce the potential of illness transmission.

Global Market Restraints

Lack of Awareness

There may be a lack of understanding and sufficient training on using and disposing of biohazard bags in specific areas or healthcare facilities. As a result, incorrect handling and disposal procedures may occur, raising the risk of infection and environmental dangers. A survey of healthcare professionals in a medical institution revealed that many lacked proper knowledge and comprehension of biohazard waste management, according to research published in the Journal of Occupational and Environmental Medicine. Many respondents were uncertain about properly categorizing and disposing of various forms of medical waste, including biohazardous items, hampering the biohazard bag market growth.

Global Market Opportunities

Growing Patient Population

The expanding patient population, particularly in infectious disease outbreaks, underlines the possibility for the market to develop and meet the growing need for safe and effective medical waste management solutions. Healthcare institutions, waste management firms, and biohazard bag manufacturers should take advantage of this chance to collaborate and develop novel solutions that address the particular demands of various healthcare environments. Companies may help with infection control, protect healthcare personnel, and preserve the environment by offering high-quality and compliant biohazard bags.

According to a World Health Organization (WHO) report, over a given number of confirmed cases worldwide as of a specified date during the COVID-19 epidemic. Because of the large number of cases, there has been a significant increase in the development of medical waste, particularly biohazardous waste, placing pressure on healthcare systems to implement adequate waste management techniques. Furthermore, public health awareness efforts emphasizing the significance of appropriate waste disposal during outbreaks may increase demand for biohazard bags. Governments and healthcare authorities may also help boost the market by supporting good waste management procedures and encouraging biohazard bags in healthcare institutions.

Segmental Analysis

The global biohazard bag market is segmented based on capacity type, material type, price type, sales channel, end-user, application, and region.

For better understanding, capacity type is further segmented into >15 Gallon, 16-30 Gallon, and>30 Gallons.

Less than 15 gallons lead the market.

Less than 15 gallons

Biohazard bags with capacities of less than 15 gallons are appropriate for smaller healthcare institutions, labs, and other places that create a reduced volume of biohazardous material. These bags are perfect for normal trash disposal and can hold a moderate amount of goods, such as worn gloves, contaminated dressings, and tiny laboratory supplies.

The market is sub-segmented by price type into Premium, Medium, and Low.

Medium pricing holds the major share.

Medium-priced

Medium-priced biohazard bags provide a mix between quality and cost. They are appropriate for many healthcare institutions, labs, and research environments that require cost-effective waste disposal solutions. These bags offer adequate protection and performance for regular biohazardous waste disposal.

Based on material type, the market can be bifurcated into HDPE (High-Density Polyethylene), High Molecular Weight HDPE, LDPE (Low-Density Polyethylene), LLDPE (Linear Low-Density Polyethylene), Polymer, Plastic, PP (Polypropylene), Others.

HDPE owns the highest share of the market.

HDPE (high-density polyethylene)

The excellent strength and durability of HDPE biohazard bags are well recognized. They are tear, puncture, and chemical resistant, making them ideal for handling heavy or sharp biohazardous trash. HDPE bags are extensively utilized in medical institutions, labs, and other environments where strong waste containment is required.

The sales channel as Modern Trade Channels, third-party online channels, direct-to-customer online channels, wholesalers/ suppliers, and local retailers categorizes this segment.

Third party online channel holds a significant share.

Third-party online channels

E-commerce platforms and marketplaces are third-party online channels where diverse vendors may list and sell their biohazard bags, including manufacturers and distributors. Customers may use these platforms to search and acquire biohazard bags from various brands and providers quickly and easily.

End-use segment can be bifurcated into commercial, industrial, and residential.

The commercial sector topped the market.

Commercial

Businesses, offices, hospitals, labs, and other institutions that create biohazard waste are included in the commercial sector. Commercial enterprises require biohazard bags to correctly dispose of medical waste, hazardous chemicals, or any other trash that provides a biological danger. For example, hospitals and laboratories create enormous volumes of medical waste that must be managed and disposed of securely using biohazard bags.

The segment can be bifurcated by application into highly infectious, other infectious, sharps, chemical and pharmaceutical, general healthcare waste, and others.

Other infectious segment is the highest contributor.

Other infectious

This application sector includes biohazardous waste that is only moderately contagious but offers a danger to human health. It comprises garbage from patients suffering from less infectious illnesses and materials contaminated with body fluids such as blood, tissues, or dirty dressings. Other infectious waste biohazard bags must also exceed safety requirements but may have somewhat different specifications than those for highly infectious waste.

Regional Analysis

North America Dominates the Global Market

The global biohazard bag market is analyzed in North America, Europe, Asia-Pacific, the Middle East and Africa, and Latin America.

North America holds a sizeable global market share and is expected to boost at a CAGR of 6.1% during the forecast period. North America is expected to account for a sizable percentage of the worldwide market for biohazard bags due to its growing aging population, highly developed healthcare system, and increased prevalence of infectious and chronic illnesses. As the prevalence of infectious illnesses rises, so will the demand for advanced surgical and medical technologies, resulting in a high number of waste products and residues. The tremendous volume of biohazard waste will boost the demand for biohazard bags in this area. Rising healthcare spending and the availability of established healthcare infrastructure are also assisting in the regional market's rise.

Additionally, the United States is one of the top contributors to the biohazard bag industry because of the country's high cancer rate. According to the American Cancer Society's Cancer Statistics 2022, 1,918,030 new cancer cases are expected in the United States in 2022. Cancer treatment frequently requires chemotherapy and radiation therapy, which are hazardous to patients, staff, and visitors. Various treatments and diagnostics also involve radioisotopes, which might cause mutations if exposed without protection. Consequently, the country's high cancer burden will likely drive development in the market throughout the forecast period.

Asia-Pacific is predicted to rise at a substantial CAGR of 6.3% throughout the forecast period, owing to a significant number of hospital beds, an expanding patient population, and multiple biohazard bag producers in the area. India and China, the two most populous countries, have around 8 million hospital beds. However, the figure falls short of the WHO-recommended number of hospital beds, five per 1000 inhabitants. Increased investment in hospital facilities and rising awareness of the benefits of effective waste management will likely drive demand for biohazard bags. Increasing investment and attempts to limit medical waste outflow have increased the demand for biohazard bags.

Furthermore, government measures to reduce market biomedical or biohazardous waste fuel growth are under consideration. For example, the Government of Japan and the United Nations Development Programme (UNDP) launched a new project in August 2022 to assist national health agencies and other key stakeholders in Bangladesh, Bhutan, and the Maldives in addressing the unprecedented rise in infectious healthcare waste caused by the COVID-19 pandemic, which is overwhelming waste treatment facilities. The USD 11 million two-year effort to improve infectious waste management will contribute to market development.

The Middle East and Africa are predicted to expand quickly during the projected period. As the amount of trash created increases, the enormous population of these continents has the potential to greatly boost demand for biohazard bags. Furthermore, according to the Kingdom of Saudi Arabia's Health Indicators 2021 report, there were 13.6 million emergency department visits, 0.5 million surgical operations, 232,216 births, and 186 million lab examinations in Saudi Arabia in 2021. As a result, the huge patient pool for medical intervention is predicted to contribute to sector growth throughout the projected period. The prospect of several deadly diseases has alerted healthcare organizations and ministries, leading to increased regional investment in hospital sterility, disinfection, and waste management.

In Latin America, the emergence of infectious illnesses has been a big driver of the biohazard bag business. For example, nations in the area have had epidemics of viruses such as dengue, Zika virus, and H1N1 influenza, which create a significant volume of infectious trash that must be safely disposed of. Biohazard bags have been used by healthcare facilities, diagnostic laboratories, and research institutes in various areas to guarantee the correct containment and disposal of infectious material.

Recent Developments

• July 2023- Merck announced the expansion of its facilities in Lenexa, Kansas, USA, adding 9,100 square meters of lab space and cell culture medium manufacturing capabilities.
• July 2023- Thermo Fisher Scientific Launches New Reproductive Health Assays to Speed Fertility Research.